JP Stock MarketDetailed Quotes

4554 Fuji Pharma

Watchlist
  • 1397
  • +3+0.22%
20min DelayMarket Closed Mar 25 15:30 JST
34.73BMarket Cap5.53P/E (Static)

Fuji Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
Total revenue
20.98%13B
12.84%46.14B
15.31%10.64B
7.50%10.75B
15.42%40.89B
11.41B
17.30%10.26B
11.46%9.23B
5.82%10B
4.22%35.43B
Cost of revenue
6.98%7.7B
16.08%28.29B
5.71%5.96B
20.65%7.19B
16.81%24.37B
6.42B
20.63%6.36B
22.35%5.64B
9.58%5.96B
8.46%20.87B
Gross profit
49.32%5.3B
8.05%17.84B
30.43%4.68B
-11.95%3.55B
13.44%16.51B
4.99B
12.25%3.9B
-2.21%3.59B
0.72%4.03B
-1.31%14.56B
Operating expense
9.72%4.05B
10.35%13.96B
4.77%3.1B
29.86%3.69B
17.40%12.65B
3.53B
29.04%3.32B
17.26%2.96B
16.42%2.84B
-5.48%10.78B
Staff costs
----
9.89%3.99B
----
----
11.42%3.63B
----
----
----
----
0.99%3.26B
Research and development costs
----
6.82%3.4B
----
----
28.13%3.18B
----
----
----
----
1.59%2.49B
Depreciation and amortization
----
16.65%1.33B
----
----
21.25%1.14B
----
----
----
----
52.76%941M
-Depreciation
----
20.48%994M
----
----
25.38%825M
----
----
----
----
94.67%658M
-Amortization
----
6.65%337M
----
----
11.66%316M
----
----
----
----
1.80%283M
Other operating expenses
----
11.56%5.24B
----
----
14.75%4.7B
----
----
----
----
8.59%4.09B
Operating profit
995.00%1.25B
0.54%3.88B
150.24%1.58B
-111.75%-140M
2.14%3.86B
1.46B
-35.74%579M
-44.91%633M
-23.80%1.19B
12.90%3.78B
Net non-operating interest income (expenses)
-94.87%-76M
-61.98%-196M
-50.00%-42M
-2.63%-39M
-57.14%-121M
-29M
-100.00%-26M
-33.33%-28M
-65.22%-38M
-45.28%-77M
Non-operating interest income
--0
----
--1M
--1M
----
----
--1M
--0
--0
----
Non-operating interest expense
90.00%76M
83.18%196M
53.57%43M
66.67%40M
38.96%107M
--28M
107.69%27M
33.33%28M
4.35%24M
45.28%77M
Total other finance cost
----
----
----
----
--14M
--0
--0
--0
--14M
----
Net investment income
6,500.00%64M
-63.73%74M
60.00%-2M
-103.85%-1M
-24.44%204M
157M
-63.38%26M
-103.76%-5M
-38.10%26M
775.00%270M
Gain(Loss) on financial instruments designated as cash flow hedges
78.57%150M
73.63%632M
218.14%649M
-70.32%84M
226.83%364M
187M
-310M
204M
283M
-287M
Gain(Loss) on derecognition of available-for-sale financial assets
0
3.12B
0
3.12B
0
0
0
Income from associates and other participating interests
Special income (charges)
-3M
694.17%713M
-11,900.00%-120M
-120M
0
96.77%-1M
Less:Other special charges
--3M
-694.17%-713M
----
----
11,900.00%120M
----
----
----
----
-95.00%1M
Other non-operating income (expenses)
-101.92%-16M
-74.65%54M
-1,156.94%-761M
612.82%834M
407.14%213M
9M
400.00%15M
213.04%72M
11,800.00%117M
700.00%42M
Income before tax
-64.42%1.37B
88.13%8.28B
147.55%2.17B
144.21%3.86B
18.16%4.4B
1.66B
-70.34%285M
-31.70%877M
-0.13%1.58B
10.44%3.72B
Income tax
-65.86%381M
120.98%2.13B
198.63%654M
140.52%1.12B
-6.14%963M
205M
-50.98%75M
-61.44%219M
0.43%464M
9.38%1.03B
Net income
-63.82%991M
78.95%6.15B
130.70%1.52B
145.87%2.74B
27.36%3.44B
1.45B
-74.01%210M
-8.10%658M
-0.36%1.11B
10.90%2.7B
Net income continuous operations
-63.83%991M
78.93%6.15B
130.55%1.52B
145.74%2.74B
27.40%3.44B
--1.45B
-74.01%210M
-8.10%658M
-0.36%1.12B
10.85%2.7B
Noncontrolling interests
0
0
0
0
0
0
0
0
0
0
Net income attributable to the company
-63.82%991M
78.92%6.15B
130.70%1.52B
145.87%2.74B
27.41%3.44B
1.45B
-74.01%210M
-8.10%658M
-0.36%1.11B
10.86%2.7B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-63.82%991M
78.92%6.15B
130.70%1.52B
145.87%2.74B
27.41%3.44B
1.45B
-74.01%210M
-8.10%658M
-0.36%1.11B
10.86%2.7B
Gross dividend payment
Basic earnings per share
-63.85%40.75
78.86%252.85
130.59%62.42
145.71%112.73
27.35%141.37
59.79
-74.06%8.63
-8.08%27.07
-0.37%45.88
22.61%111.01
Diluted earnings per share
-63.85%40.75
78.86%252.85
130.59%62.42
145.71%112.73
27.35%141.37
59.7873
-74.06%8.63
-8.08%27.07
-0.37%45.88
22.61%111.01
Dividend per share
0
14.86%42.5
17.65%20
0
5.71%37
20
0
13.33%17
0
20.69%35
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022
Total revenue 20.98%13B12.84%46.14B15.31%10.64B7.50%10.75B15.42%40.89B11.41B17.30%10.26B11.46%9.23B5.82%10B4.22%35.43B
Cost of revenue 6.98%7.7B16.08%28.29B5.71%5.96B20.65%7.19B16.81%24.37B6.42B20.63%6.36B22.35%5.64B9.58%5.96B8.46%20.87B
Gross profit 49.32%5.3B8.05%17.84B30.43%4.68B-11.95%3.55B13.44%16.51B4.99B12.25%3.9B-2.21%3.59B0.72%4.03B-1.31%14.56B
Operating expense 9.72%4.05B10.35%13.96B4.77%3.1B29.86%3.69B17.40%12.65B3.53B29.04%3.32B17.26%2.96B16.42%2.84B-5.48%10.78B
Staff costs ----9.89%3.99B--------11.42%3.63B----------------0.99%3.26B
Research and development costs ----6.82%3.4B--------28.13%3.18B----------------1.59%2.49B
Depreciation and amortization ----16.65%1.33B--------21.25%1.14B----------------52.76%941M
-Depreciation ----20.48%994M--------25.38%825M----------------94.67%658M
-Amortization ----6.65%337M--------11.66%316M----------------1.80%283M
Other operating expenses ----11.56%5.24B--------14.75%4.7B----------------8.59%4.09B
Operating profit 995.00%1.25B0.54%3.88B150.24%1.58B-111.75%-140M2.14%3.86B1.46B-35.74%579M-44.91%633M-23.80%1.19B12.90%3.78B
Net non-operating interest income (expenses) -94.87%-76M-61.98%-196M-50.00%-42M-2.63%-39M-57.14%-121M-29M-100.00%-26M-33.33%-28M-65.22%-38M-45.28%-77M
Non-operating interest income --0------1M--1M----------1M--0--0----
Non-operating interest expense 90.00%76M83.18%196M53.57%43M66.67%40M38.96%107M--28M107.69%27M33.33%28M4.35%24M45.28%77M
Total other finance cost ------------------14M--0--0--0--14M----
Net investment income 6,500.00%64M-63.73%74M60.00%-2M-103.85%-1M-24.44%204M157M-63.38%26M-103.76%-5M-38.10%26M775.00%270M
Gain(Loss) on financial instruments designated as cash flow hedges 78.57%150M73.63%632M218.14%649M-70.32%84M226.83%364M187M-310M204M283M-287M
Gain(Loss) on derecognition of available-for-sale financial assets 03.12B03.12B000
Income from associates and other participating interests
Special income (charges) -3M694.17%713M-11,900.00%-120M-120M096.77%-1M
Less:Other special charges --3M-694.17%-713M--------11,900.00%120M-----------------95.00%1M
Other non-operating income (expenses) -101.92%-16M-74.65%54M-1,156.94%-761M612.82%834M407.14%213M9M400.00%15M213.04%72M11,800.00%117M700.00%42M
Income before tax -64.42%1.37B88.13%8.28B147.55%2.17B144.21%3.86B18.16%4.4B1.66B-70.34%285M-31.70%877M-0.13%1.58B10.44%3.72B
Income tax -65.86%381M120.98%2.13B198.63%654M140.52%1.12B-6.14%963M205M-50.98%75M-61.44%219M0.43%464M9.38%1.03B
Net income -63.82%991M78.95%6.15B130.70%1.52B145.87%2.74B27.36%3.44B1.45B-74.01%210M-8.10%658M-0.36%1.11B10.90%2.7B
Net income continuous operations -63.83%991M78.93%6.15B130.55%1.52B145.74%2.74B27.40%3.44B--1.45B-74.01%210M-8.10%658M-0.36%1.12B10.85%2.7B
Noncontrolling interests 0000000000
Net income attributable to the company -63.82%991M78.92%6.15B130.70%1.52B145.87%2.74B27.41%3.44B1.45B-74.01%210M-8.10%658M-0.36%1.11B10.86%2.7B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -63.82%991M78.92%6.15B130.70%1.52B145.87%2.74B27.41%3.44B1.45B-74.01%210M-8.10%658M-0.36%1.11B10.86%2.7B
Gross dividend payment
Basic earnings per share -63.85%40.7578.86%252.85130.59%62.42145.71%112.7327.35%141.3759.79-74.06%8.63-8.08%27.07-0.37%45.8822.61%111.01
Diluted earnings per share -63.85%40.7578.86%252.85130.59%62.42145.71%112.7327.35%141.3759.7873-74.06%8.63-8.08%27.07-0.37%45.8822.61%111.01
Dividend per share 014.86%42.517.65%2005.71%3720013.33%17020.69%35
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP